COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease. La présente div...

Full description

Saved in:
Bibliographic Details
Main Authors FLEISHER, ADAM S, LO, ALBERT, SIMS, JOHN RANDALL II, WALSH, ROBIN ELIZABETH, SKORA, ANDREW DIXON, RAINES, SARAH ELISABETH, LANNAN, MEGAN BRITTANY, MINTUN, MARK, WEST, ELIZABETH ANNE, YE, MING, CHEDID, MARCIO, OBUNGU, VICTOR H
Format Patent
LanguageEnglish
French
Published 04.05.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease. La présente divulgation concerne des anticorps anti-IL-34, des compositions les comprenant, et des procédés d'utilisation desdits anticorps et ou des compositions de ceux-ci pour traiter des maladies à médiation immunitaire telles que des maladies neurodégénératives, par exemple la maladie d'Alzheimer ou une tauopathie.
Bibliography:Application Number: CA20223236504